Cleared Special

K251560 - FUBUKI XF-R Neurovascular Long Sheath

K251560 is the FDA 510(k) clearance for FUBUKI XF-R Neurovascular Long Sheath by Asahi Intecc Co., Ltd.. It is a Class 2 Neurology device (product code QJP) cleared through the Special 510(k) pathway after a 30-day FDA review.

K251560 · Asahi Intecc Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2025
Decision
30d
Days
Class 2
Risk

K251560 is an FDA 510(k) clearance for the FUBUKI XF-R Neurovascular Long Sheath. Classified as Catheter, Percutaneous, Neurovasculature (product code QJP), Class II - Special Controls.

Submitted by Asahi Intecc Co., Ltd. (Seto, JP). The FDA issued a Cleared decision on June 20, 2025 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Asahi Intecc Co., Ltd. devices

Submission Details

510(k) Number K251560 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 21, 2025
Decision Date June 20, 2025
Days to Decision 30 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
118d faster than avg
Panel avg: 148d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code QJP Catheter, Percutaneous, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
Definition To Provide Vascular Access To The Neurovasculature For Interventional Or Diagnostic Procedures
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Asahi Intecc USA, Inc.
Esther Kim

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - QJP Catheter, Percutaneous, Neurovasculature

All 90
Devices cleared under the same product code (QJP) and FDA review panel - the closest regulatory comparables to K251560.
Carrier XL Delivery Catheter
K252569 · Balt USA, LLC · Oct 2025
DUO Microcatheter
K250960 · Rev Neuro, LLC · Sep 2025
Branchor X Balloon Guide Catheter
K251240 · Asahi Intecc Co., Ltd. · Jun 2025
93 NeuFlex Catheter
K251044 · Piraeus Medical · May 2025
PATH BGC
K242392 · Crossroads Neurovascular, Inc. · May 2025
Excelsior XT-27 Microcatheter, Excelsior XT-27 Flex Microcatheter, Excelsior XT-27 Pre-Shaped Microcatheter, Excelsior XT-27 Flex Pre-Shaped Microcatheter
K242289 · Stryker Neurovascular · Mar 2025